An Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and …

J Piestansky, I Cizmarova, P Mikus… - Therapeutic Drug …, 2022 - journals.lww.com
Background: Optimization of antimicrobial therapy is a challenge in critically ill patients who
develop extreme interindividual and intraindividual pharmacokinetic variability. Therapeutic …
被引用次数：7 相关文章

An Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and …

J Piestansky, I Cizmarova, P Mikus… - Therapeutic Drug …, 2022 - journals.lww.com
Background: Optimization of antimicrobial therapy is a challenge in critically ill patients who
develop extreme interindividual and intraindividual pharmacokinetic variability. Therapeutic …

An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and …

J Piestansky, I Cizmarova, P Mikus… - Therapeutic Drug …, 2022 - europepmc.org
Background Optimization of antimicrobial therapy is a challenge in critically ill patients who
develop extreme interindividual and intraindividual pharmacokinetic variability. Therapeutic …

An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and …

J Piestansky, I Cizmarova, P Mikus… - Therapeutic drug …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Optimization of antimicrobial therapy is a challenge in critically ill patients who
develop extreme interindividual and intraindividual pharmacokinetic variability. Therapeutic …

An Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and …

J Piestansky, I Cizmarova, P Mikus… - Therapeutic Drug …, 2022 - ingentaconnect.com
Background: Optimization of antimicrobial therapy is a challenge in critically ill patients who
develop extreme interindividual and intraindividual pharmacokinetic variability. Therapeutic …